Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14910]

The inaugural WHO classification of childhood tumours will provide a unified, updated resource for the diagnosis of paediatric cancers

The inaugural WHO classification of childhood tumours will provide a unified, updated resource for the diagnosis...

New model reveals achieving an 80% HPV vaccination rate could eliminate nearly 1 million cases of male oropharyngeal cancer this century

New model reveals achieving an 80% HPV vaccination rate could eliminate nearly 1 million cases of male...

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

New liquid biopsy detects local immune activity

New liquid biopsy detects local immune activity

Creating a checklist for bringing oncogenomics in paediatrics into world healthcare systems

Creating a checklist for bringing oncogenomics in paediatrics into world healthcare systems

ASH 2021: Researchers present encouraging clinical trial results on novel therapy for bone marrow cancer

ASH 2021: Researchers present encouraging clinical trial results on novel therapy for bone marrow cancer

Improving drug options for colorectal cancer patients

Improving drug options for colorectal cancer patients

ASH 2021: Retrospective analysis of frontline treatment approach with treated secondary AML

ASH 2021: Retrospective analysis of frontline treatment approach with treated secondary AML

ASH 2021: Azacitidine with venetoclax and magrolimab shows high response rates in patients with newly diagnosed older/unfit or high-risk AML

ASH 2021: Azacitidine with venetoclax and magrolimab shows high response rates in patients with newly diagnosed...

$ASH 2021: Venetoclax in combination with gilteritinib demonstrates molecular clearance of FLT3 mutation in relapsed/refractory FLT3-mutated AML$

ASH 2021: Venetoclax in combination with gilteritinib demonstrates molecular clearance of FLT3 mutation in...

More from ecancer